Skip to main content
Figure 9 | Molecular Cancer

Figure 9

From: Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors

Figure 9

c-Myc overexpression attenuates U0126 differentiative effects. Immunoblotting with specific antibodies for indicated proteins of cell lysates from c-Myc polyclonal population of RD cells left untreated or treated with U0126. α-tubulin expression shows the loading of samples. The histograms (right panel) show the values of fold increases over the control, arbitrarly set at 1, obtained by densitometric analysis of the immunoblottings. Similar results were obtained in two experiments.

Back to article page

Molecular Cancer

ISSN: 1476-4598